Sign In
Buy DRIO
$7.50
-0.1000 (-1.32%)
At Close: Jun 05, 2026
Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care
08:30am, Monday, 13'th Oct 2025
New clients span multiple industries and underscore broad increasing demand for Dario's multi-condition digital health platform Innovative new pricing model is highly attractive to prospective clients
Collaboration designed to drive measurable return on investment ("ROI") for health plans by reducing falls and improving outcomes for high-risk populations, including those with obesity and Medicare A
DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest
06:00am, Thursday, 25'th Sep 2025
Board forms Special Committee and engages Perella Weinberg Partners as financial advisor Company completed an oversubscribed $17.5 million private placement to capitalize on significant commercial mom
DarioHealth Announces $17.5 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules
07:00am, Monday, 22'nd Sep 2025
NEW YORK , Sept. 22, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a private placement for the purchas
DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market
08:30am, Wednesday, 03'rd Sep 2025
NEW YORK , Sept. 3, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today issued a shareholder update highlighting stra
New customer launches representing 107,000 lives covered reinforce Dario's B2B2C momentum and recurring revenue growth Dario's multi-condition digital health solutions deliver real-time results for pr
DarioHealth Announces 20-to-1 Reverse Stock Split
08:00am, Monday, 25'th Aug 2025
NEW YORK , Aug. 25, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced that a reverse stock split of the C
DarioHealth Corp. (DRIO) Reports Q2 Loss, Misses Revenue Estimates
04:01pm, Tuesday, 12'th Aug 2025
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to earnings of $0.06 per share a year ago.
DarioHealth Corp. (DRIO) Q2 2025 Earnings Call Transcript
12:15pm, Tuesday, 12'th Aug 2025
DarioHealth Corp. (NASDAQ:DRIO ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Chen Franco-Yehuda - CFO, Treasurer & Secretary Erez Raphael - CEO & Director Steven C
DarioHealth Reports Second Quarter 2025 Financial and Operating Results
06:30am, Tuesday, 12'th Aug 2025
Second quarter 2025 revenue was $5.4 million, compared to $6.3 million in the second quarter of 2024, and $6.8 million in the first quarter of 2025 - The Company believes that strong client momentum a
DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025
08:30am, Tuesday, 05'th Aug 2025
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK , Aug. 5, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digit
Dario and GreenKey Join Forces to Target $150 Billion Sleep Apnea Market, Addressing 29 Million Americans with Unmet Needs Through Integrated Chronic Care Solution NEW YORK and SAN FRANCISCO , June 26
Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings
08:30am, Tuesday, 24'th Jun 2025
Dario's new research shows sustained outcomes post-GLP-1 for platform users and 89% accuracy in innovative AI blood glucose prediction; the Company is actively working to leverage these findings in co
DarioHealth Corp. (DRIO) Q1 2025 Earnings Call Transcript
11:15am, Wednesday, 14'th May 2025
DarioHealth Corp. (NASDAQ:DRIO ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Lara Dod
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
08:40am, Wednesday, 14'th May 2025
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.20 per share a year ago.
